Gains in sports medicine, extremities, advanced biologics and joint fluid offset softening spine market

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 OrthoBio Market Recap and Financial Dashboard.

Despite some challenges in 2017, the US OrthoBio market finished strong, growing 5.3% to $3.46B. Gains in Sports Medicine, Extremities, Advanced Biologics and Joint Fluid countered the softening Spine market and lower growth rates of core biologics. Positive results stemmed from incremental pull through revenue from synergistic sales strategies, entry of new companies, introduction of new products, growth in new surgeon users and use of biologics in non-traditional applications ...

Among the topics covered in the Q417, FY17 OrthoBio Market Recap are:

SmartTRAK will be hosting an Executive Briefing and Reception titled "Advanced Wound Care: Trends, Opportunities & Innovation"  at the 2018 SAWC Spring - The Symposium on Advanced Wound Care - on Wednesday, April 25th at 5pm in the Westin Charlotte Hotel, Uptown Room.

Moderated by Don Urbanowicz, Principal, Urbanowicz Consulting, the panel will include Susan Paquette, VP & GM Wound, BioMedGPS and Lennart Stadler, SmartTRAK's Senior Analyst, Wound Care. The discussion will focus on the latest trends and technologies impacting the Global Advanced Wound Care Market.

            

The US market for Hemostats and Sealants recovered in Q417, up +5.0% YoY, in line with historic growth rates. While biologic sealants continue to lag, every other segment grew, led by absorbable hemostats and fibrin sealants.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 Hemostats & Sealants Market Recap and Financial Dashboard.

As reported in SmartTRAK’s Financial Dashboard, almost every manufacturer competing in the Hemostats and Sealants market saw revenue growth in Q417/FY17, led by Baxter, Ethicon and Cryolife in Q417 and by Baxter and Integra for FY17 ...

US Extremities Market experiences bump w/ new competition expected to fuel future growth

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its  2017 Extremities Market Recap and  Financial Dashboard.

 The US Extremities Market experienced an overall bump in Q417 growth that extended into all categories, with the exception of Ankle Replacement that took a slight dip in Q417, with sequential growth down from 18.1% to 16.1%. ...

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its  2017 Trauma Market Recap and  Financial Dashboard.

Despite slightly tougher US comps in Q4, the Trauma Market ended 2017 with steady, mid-single-digit growth primarily driven from the IM Nailing segment. The strength of the IM Nailing segment has been a multi-year story as a result of trauma market leader DePuy Synthes’ TFNA Nail boosting sales each quarter. Other players such as Smith & Nephew and Zimmer Biomet have followed suit touting their own hip and femur nails as growth drivers during the quarter ...

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care  companies, has published its 2017 Total Joints Market Recap and Financial Dashboard.

The Total Joints Market finished off a challenging year with accelerated growth in Q417, despite increasing pricing pressure. Hurricanes in Q3 and increased seasonality due to higher insurance deductibles pushed procedures into Q4 driving stronger sequential growth. Increasing penetration of robotics resulted in uptake of new products, including Stryker’s MAKO robotic TKA application for Triathlon knees.

SmartTRAK is excited to be attending #ASIPP 2018 - the 20th Annual Meeting of the American Society of Interventional Pain Physicians on March 15-17 at  the Marriot Orlando World Center in Orlando, Florida.

The educational events at ASIPP will include practice management, controlled substance management, regenerative medicine, interventional techniques, abstract presentations, a Resident/Fellow section for emergence into practice and much more. 

Anne Staylor,  Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be representing BioMedGPS SmartTRAK at the conference. Please contact us if you would like a meeting.

Scott Drees, CEO of Nuvectra Corporation, discusses the Company’s challenges and opportunities in 2017, strategies for driving growth and market penetration in neuromodulation, and the Company’s key priorities for 2018 in an interview with SmartTRAK at the North American Neuromodulation Society Annual Meeting held Jan. 11-14, 2018 in Las Vegas, NV.

A transcript of SmartTRAK’s interview with Scott Drees is below, or click the following video to view the interview recorded live at NANS 2018. (17:41 minutes.)

SmartTRAK hosted a forward-thinking panel discussion titled "Ortho 2020: Joints, Biologics and Supply Chain Innovation" at #AAOS2018, the American Academy of Orthopaedic Surgeons meeting in New Orleans.

Becker’s October 2017 Hospital Review webinar on “Current Trends for Success in Bundles and Strategies for Financial Changes: Orthopedics and Beyond” provides insights into the delicate balance healthcare institutions and surgeons are trying to maintain in this cost-conscious environment. Joseph Bosco, MD, and Richard Iorio, MD, of NYU Hospital for Joint Diseases shared their experience with everything from maximizing reimbursements and cost-effectively managing patient care while maintaining and improving clinical outcomes.

 Dr. Bosco, holds the positions of Vice Chairman of Clinical Affairs, and Director of the Center for Quality and Patient Safety. Dr. Iorio serves as Chief of Adult Reconstruction and as the chair of the American Association of Hip and Knee Surgeons Committee on Advocacy and Healthcare Policy. Both Bosco and Iorio are principals with Labrador Healthcare Consulting, a value-based reimbursement strategies advisory firm. Below are highlights from the webinar: